financetom
Business
financetom
/
Business
/
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Full Circle Lithium Sales of Lithium-ion Battery Firefighting Agent Pass US$300,000
Nov 11, 2024 5:52 AM

08:28 AM EST, 11/11/2024 (MT Newswires) -- Full Circle Lithium ( FCLIF ) , a U.S.-based lithium-products manufacturer, on Monday said that sales of FCL-X, the company's lithium-ion battery fire-extinguishing agent, has surpassed US$300,000.

"We are very pleased to see that we achieved meaningful non-recurring sales of FCL-X in all product lines in the past few weeks even though we have just begun our marketing and sales efforts, including signing up with US specialty fire safety distributor AEST Fire & Safety," said CEO Carlos Vicens.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AST SpaceMobile Secures Special Temporary Authority From FCC for Testing Service in US
AST SpaceMobile Secures Special Temporary Authority From FCC for Testing Service in US
Jan 31, 2025
05:04 AM EST, 01/31/2025 (MT Newswires) -- AST SpaceMobile ( ASTS ) said late Thursday it has received a special temporary authority from the Federal Communications Commission authorizing the company's testing service in the US. The authority enables the company's first five commercial BlueBird satellites with unmodified smartphones with partners AT&T ( T ) and Verizon (VZ) to support voice,...
Vertex Pharmaceuticals Sickle Cell Therapy to be Reimbursed by England's National Health Service
Vertex Pharmaceuticals Sickle Cell Therapy to be Reimbursed by England's National Health Service
Jan 31, 2025
04:55 AM EST, 01/31/2025 (MT Newswires) -- Vertex Pharmaceuticals ( VRTX ) said Friday it has made a reimbursement agreement with National Health Service England for eligible sickle cell disease patients to access the CRISPR/Cas9 gene-edited therapy, Casgevy. The reimbursement agreement coincides with the UK National Institute for Health and Care Excellence recommending Casgevy's use by the NHS, the company...
India's top drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
India's top drugmaker Sun Pharma's Q3 profit beats estimates on strong local sales
Jan 31, 2025
HYDERABAD/BENGALURU Jan 31 (Reuters) - Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected quarterly profit on Friday, aided by strong sales in the domestic market. The Mumbai-based firm's consolidated net profit rose 15% to 29.03 billion rupees ($335.3 million) in third quarter, beating analysts' average estimate of 28.81 billion rupees, according to data compiled by LSEG. ($1 =...
Viper Energy Prices $1.1 Billion Upsized Stock Offering
Viper Energy Prices $1.1 Billion Upsized Stock Offering
Jan 31, 2025
04:44 AM EST, 01/31/2025 (MT Newswires) -- Viper Energy ( VNOM ) said Thursday it has priced an expanded public offering of 24.6 million Class A common shares at $44.5 per share, increasing by 2.6 million shares compared to the initial plan. Underwriters have a 30-day option to buy up to 3.7 million extra shares at the offering price, the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved